Trials / Completed
CompletedNCT05922722
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
Clarifying Misbeliefs About Hydroxychloroquine (HCQ): Developing an Individualized Decision Aid for Diverse Patients With Lupus (HCQ-IDEAL)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase medication adherence. Participants will be asked to complete questionnaires that assess their understanding of the decision-making tool.
Detailed description
This study will be no different from a routine lupus or lupus nephritis clinic visit. During the same visit that a participant routinely does for lupus with their healthcare team, a healthcare team member will discuss the tool that elaborates the benefits vs. risks of lupus medications such as hydroxychloroquine. Participants will complete questionnaires that assesses their understanding of the medication (hydroxychloroquine) before and after they complete the discussion regarding the medication using the tool with the healthcare team member. Study team members will study the data collected to answer research questions. They will analyze the data and plan better steps improve care quality in lupus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Decision-making tool | The shared decision-making tool is a paper tool or an electronic version which will be available in the clinics for clinic team's use. |
| OTHER | Questionnaire | Questionnaire to assess participant's understanding of the decision-making tool |
Timeline
- Start date
- 2024-02-15
- Primary completion
- 2025-02-20
- Completion
- 2025-02-20
- First posted
- 2023-06-28
- Last updated
- 2025-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05922722. Inclusion in this directory is not an endorsement.